Abvc Biopharma, Inc. (ABVC): Net Income
-$7.91M
Year ended 2025-12-31
-$7.11M
Trailing 12 months to 2026-06-30
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$7.91M | n/m | 2026-03-03, From 2025-01-01 |
| 2024-12-31 | -$4.90M | n/m | 2026-03-03, From 2024-01-01 |
| 2023-12-31 | -$7.79M | n/c | 2025-04-15, From 2023-01-01 |
| 2022-12-31 | -$16.42M | n/m | 2024-03-13, From 2022-01-01 |
| 2021-12-31 | -$12.84M | n/c | 2023-03-31, From 2021-01-01 |
| 2020-12-31 | -$10.59M | n/m | 2022-03-31, From 2020-01-01 |
| 2019-12-31 | -$3.93M | n/m | 2021-03-16, From 2019-01-01 |
| 2018-12-31 | -$6.06M | n/c | 2020-05-15, From 2018-01-01 |
| 2017-12-31 | -$4.24M | n/a | 2019-04-15, From 2017-01-01 |
| No annual figure between 2016-09-30 and 2017-12-31. | |||
| 2016-09-30 | -$11.01M | n/m | 2018-01-16, From 2015-10-01 |
| 2015-09-30 | -$32.3K | n/m | 2015-11-27, From 2014-10-01 |
| 2014-09-30 | -$23.2K | n/m | 2015-11-27, From 2013-10-01 |
| 2013-09-30 | -$226.4K | n/m | 2015-04-17, From 2012-10-01 |
| 2012-09-30 | -$1.07M | n/m | 2015-04-16, From 2011-10-01 |
| 2011-09-30 | -$1.22M | n/m | 2015-04-15, From 2010-10-01 |
| 2010-09-30 | -$1.90M | n/a | 2011-12-28, From 2009-10-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Abvc Biopharma, Inc. (ABVC) | 2025-12-31 | -$7.91M | n/m |
| Vyome Holdings, Inc (HIND) | 2025-12-31 | -$10.26M | n/m |
| Allarity Therapeutics, Inc. (ALLR) | 2025-12-31 | -$11.23M | n/m |
| Provectus Biopharmaceuticals, Inc. (PVCT) | 2025-12-31 | -$5.43M | n/m |
| Regen BioPharma Inc (RGBP) | 2025-09-30 | -$1.27M | n/m |
| America Great Health (AAGH) | 2025-06-30 | -$719.1K | n/m |
| Can-Fite BioPharma Ltd. (CANF) | 2025-12-31 | -$9.83M | n/m |
| Medicinova Inc (MNOV) | 2025-12-31 | -$12.00M | n/m |
| Scienture Holdings, Inc. (SCNX) | 2025-12-31 | -$41.51M | n/m |
Compare ABVC, HIND, ALLR, PVCT side by side · Screen every company in Pharmaceutical Preparations ↗